Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001415889-23-010720 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-06-30 | VTGN | Adler Reid G. | CLO | A - Grant | $1.59 | +167 | 11.5K | +1% | +$265.53 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | A | A | 167 | $1.59 | 11,488 | D | — | — | (F1) Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP"). |